U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230028) titled 'Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.' on Sept. 17.
Brief Summary: The goal of this clinical trial is to learn if hydroxychloroquine works to treat long-term complaints attributed to Lyme borreliosis in adults. The main questions it aims to answer are:
Does addition of hydroxychloroquine reduce physical complaints? Researchers will compare hydroxychloroquine to a placebo (a look-alike substance that contains no drug) to see if hydroxychloroquine works to treat Lyme borreliosis.
Participants will:
Take hydroxychloroquine or a placebo two times a day during 28 days. Visit the clinic 4 times in one year for ch...